|
Gu, Lubing; Findley, Harry W; Zhou, Muxiang (2002) MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 99:3367-75
|
|
Zhou, M; Gu, L; Holden, J et al. (2000) CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3. Leukemia 14:403-11
|
|
Zhou, M; Gu, L; Abshire, T C et al. (2000) Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Leukemia 14:61-7
|
|
Findley, H W; Zhou, M (1999) The clinical significance of Fas expression in leukemia: questions and controversies. Leukemia 13:147-9
|
|
Boayue, K B; Gu, L; Yeager, A M et al. (1998) Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin. Leukemia 12:182-91
|
|
Zhou, M; Gu, L; Yeager, A M et al. (1998) Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. Leukemia 12:1756-63
|
|
Gu, L; Zhou, M; Jurickova, I et al. (1997) Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: a possible target for therapy with recombinant IL6-Pseudomonas exotoxin. Leukemia 11:1779-86
|
